Astragalus Polysaccharide RAP Selectively Attenuates Paclitaxel-Induced Cytotoxicity Toward RAW 264.7 Cells by Reversing Cell Cycle Arrest and Apoptosis

Frontiers in Pharmacology
Wan-Rong BaoQuan-Bin Han

Abstract

Purpose: The purpose of this study was to determine if an Astragalus polysaccharide (RAP) can protect immune cells from the toxic side effects of paclitaxel (Taxol), a powerful anti-tumor drug whose equally powerful side effects limit its clinical use. Methods: We hypothesized that RAP can reduce the toxic effects induced by Taxol. To test this hypothesis, we conducted a series of studies in vivo and in vitro. First, we confirmed RAP's effects in vivo utilizing BALB/c mice inoculated with 4T1 mouse breast cancer cells as the tumor model. Mice were treated with RAP and/or Taxol, and the differences in the life spans were recorded. Second, a co-culture cell model was used to study the protective effect of RAP on cells vis-a-vis Taxol. The cell cycle and apoptosis of RAW 264.7 cells that were treated with RAP with/without Taxol were checked by flow cytometry and Hoechst staining. Proteins involved in the cell cycle and apoptosis were also tested by Western blot to reveal the probable mechanism. Results: RAP prolonged the life span of tumor-bearing mice treated with Taxol. The in vitro experiments showed that Taxol suppressed the proliferation of RAW 264.7 cells while RAP protected the RAW 264.7 cells from Taxol-induced suppression...Continue Reading

References

Oct 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B S ReichmanC A Hudis
Jul 4, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E D Razis, G Fountzilas
Jan 28, 2004·Cell·Sepideh Khorasanizadeh
Jul 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Feng HongGordon D Ross
Jun 14, 2005·Cancer Investigation·Federico Pellegrini, Daniel R Budman
May 23, 2006·Pharmaceutical Research·Sandra PeltierJean-Pierre Benoît
Dec 28, 2007·The New England Journal of Medicine·Kathy MillerNancy E Davidson
Feb 15, 2008·Journal of Pharmaceutical and Biomedical Analysis·Jing-Zheng SongHong-Xi Xu
Aug 20, 2010·Science Translational Medicine·Wing LamYung-Chi Cheng
Feb 14, 2012·Journal of Ethnopharmacology·Shwu-Huey Liu, Yung-Chi Cheng
Jan 15, 2014·Anti-cancer Drugs·Mansukh C Wani, Susan Band Horwitz
Sep 13, 2014·Molecular Biology of the Cell·Beth A Weaver
Mar 24, 2015·Colloids and Surfaces. B, Biointerfaces·Hima Bindu Ruttala, Young Tag Ko
Jul 3, 2015·BioMed Research International·Nirmala Chandralega KampanMagdalena Plebanski
Dec 9, 2015·Chinese Journal of Integrative Medicine·Yeehong JungSookyung Lee
Feb 3, 2016·The Journal of Cell Biology·Valentin MagidsonAlexey Khodjakov
Feb 27, 2016·The American Journal of Chinese Medicine·Kathy K AuyeungJoshua K Ko
Sep 22, 2016·Proceedings of the National Academy of Sciences of the United States of America·Chia-Ping Huang YangSusan Band Horwitz
Oct 21, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Li BoCaoyun Xia
Aug 10, 2017·International Journal of Molecular Sciences·Chia-Ping Huang Yang, Susan Band Horwitz
Aug 16, 2017·Endocrine-related Cancer·Roberta Visconti, Domenico Grieco
Jan 9, 2018·Chemical Communications : Chem Comm·Xiaoli ZhangZhimou Yang
Apr 17, 2018·Journal of Agricultural and Food Chemistry·Quan-Bin Han
Oct 1, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Hiroshi YoneyamaKoichiro Atsuda

❮ Previous
Next ❯

Methods Mentioned

BETA
RAP
AFM
protein assay
flow cytometry

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis